Congress Asset Management’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $542K | Buy |
156,700
+498
| +0.3% | +$1.72K | ﹤0.01% | 339 |
|
|
2025
Q1 | $409K | Sell |
156,202
-1,283
| -0.8% | -$3.36K | ﹤0.01% | 334 |
|
|
2024
Q4 | $649K | Buy |
157,485
+11,061
| +8% | +$45.6K | ﹤0.01% | 335 |
|
|
2024
Q3 | $1.04M | Sell |
146,424
-1,186
| -0.8% | -$8.4K | 0.01% | 298 |
|
|
2024
Q2 | $962K | Sell |
147,610
-1,472
| -1% | -$9.6K | 0.01% | 299 |
|
|
2024
Q1 | $1.24M | Buy |
149,082
+2,108
| +1% | +$17.5K | 0.01% | 292 |
|
|
2023
Q4 | $1.62M | Buy |
146,974
+540
| +0.4% | +$5.95K | 0.01% | 302 |
|
|
2023
Q3 | $1.23M | Buy |
146,434
+207
| +0.1% | +$1.74K | 0.01% | 298 |
|
|
2023
Q2 | $1.84M | Buy |
+146,227
| New | +$1.84M | 0.02% | 287 |
|